Stevens Capital Management LP Novo Nordisk A S Transaction History

Stevens Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $571,872 - $630,505	-8,979 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$58.54 - $67.94 $525,630 - $610,033	8,979 New	8,979 $588,000
Q1 2020 Apr 21, 2020	SELL	$49.46 - $64.78 $450,184 - $589,627	-9,102 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$49.86 - $58.26 $453,825 - $530,282	9,102 New	9,102 $527,000
Q3 2018 Nov 13, 2018	SELL	$46.76 - $51.24 $204,949 - $224,584	-4,383 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$44.29 - $50.42 $194,123 - $220,990	4,383 New	4,383 $202,000
Q4 2017 Feb 13, 2018	SELL	$47.53 - $53.73 $221,584 - $250,489	-4,662 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$41.15 - $49.22 $191,841 - $229,463	4,662	4,662 $224,000

1,952

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $232B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.